Fusion event
HBV-SYTL2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATA| |CTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCA
End
85467604/85756561 (Hg38)
miRNAs that regulate target gene
Nearest miRNA
hsa-mir-10392/Upstream/3865725; hsa-let-7a-2/Downstream/521772;
Upstream sequence
GTTAACAAATGAGTACCTaagactgggatttgattctcacttctgacacctaccagttgtgtgatattgggcgagtcacctgacttgtctcaaagtcaac
Downstream sequence
ttcctgacacatcaaatggggtaattatatcccactccacccaccaaccgcaaaagagtatgtgagctcataaaaaataatgggcatgttaagccctttg
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.